XRP (CRYPTO: XRP) is holding key support levels amid fresh ETF filings, heavy whale activity and growing optimism over regulatory approval.

This suggests that the company maintains a reasonable level of debt while also leveraging equity financing.

United Therapeutics' Tyvaso showed significant lung function improvement in IPF patients, with plans to seek FDA approval for expanded use.

BRP reported quarterly earnings of 67 cents per share which beat the analyst consensus estimate of 33 cents per share. The company reported quarterly sales of $1.374 billion which beat the analyst ...

Analyst Fawne Jiang reiterates Buy rating for Alibaba (BABA) with $195 price target. Strong cloud & e-commerce growth, potential for market share gains & multiple expansion.

Orla Mining (ORLA) has outperformed the market over the past 5 years by 8.36% on an annualized basis producing an average annual return of 22.22%. Currently, Orla Mining has a market capitalization of ...

Despite the top-line beat, adjusted earnings per American Depositary Share (ADS) came in at $2.06, falling short of the analyst consensus of $2.13. Alibaba CEO Eddie Wu said the company drove strong ...

Analysts anticipate Methode Electronics to report an earnings per share (EPS) of $-0.31. Anticipation surrounds Methode Electronics's announcement, with investors hoping to hear about both surpassing ...

Debt Management: ChargePoint Hldgs's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.72, the company relies more heavily on borrowed funds, indicating a higher ...

The consensus rating for Tilly's is Neutral, based on 1 analyst ratings. With an average one-year price target of $2.0, there's a potential 1.52% upside.

PagerDuty (PD) is gearing up to announce its quarterly earnings on Wednesday, 2025-09-03. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

FinVolution Group has a lower P/E than the aggregate P/E of 47.28 of the Consumer Finance industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable ...